✦ LIBER ✦

A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102

✍ Scribed by George K. Philips; Susan Halabi; Ben L. Sanford; Dean Bajorin; Eric J. Small; Cancer; Leukaemia Group B

Book ID: 109053591
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 116 KB
Volume: 0
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2007.07226.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

GEMCITABINE PLUS CISPLATIN FOR ADVANCED

GEMCITABINE PLUS CISPLATIN FOR ADVANCED TRANSITIONAL CELL CARCINOMA OF THE URINARY TRACT: A PHASE II MULTICENTER TRIAL

✍ LORUSSO, VITO; MANZIONE, LUIGI; DE VITA, FERDINANDO; ANTIMI, MAURO; SELVAGGI, FR 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 51 KB

Phase II clinical trial of induction che

Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer

✍ Jae-Sung Kim, Joo Han Lim, Jee Hyun Kim… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 234 KB

Ifosfamide, paclitaxel, and cisplatin fo

Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract : Final report of a Phase II trial evaluating two dosing schedules

✍ Dean F. Bajorin; John A. McCaffrey; Paul M. Dodd; Susan Hilton; Madhu Mazumdar; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## BACKGROUND. A combination regimen of ifosfamide, paclitaxel, and cisplatin (ITP), recycled every 4 weeks, was reported in the treatment of previously untreated patients with advanced transitional cell carcinoma (TCC). This study sought to examine ITP at 3-week intervals to assess its feasibility

Prospective phase II trial of a combinat

Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma

✍ SHIN, S; KIM, H; BAEK, J; AHN, J; JEGAL, Y; SEO, K; PARK, C; SHIN, J; JUNG, J; K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Phase II trial with a new schedule of ge

Phase II trial with a new schedule of gemcitabine and cisplatin for the treatment of advanced non-small cell lung cancer

✍ Chacon, J.I; Andrade, J; Lopez, L; Martinez, B; Cruz, M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A randomised phase II trial of weekly hi

A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial

✍ M. Ducreux; E. Van Cutsem; J.L. Van Laethem; T.M. Gress; K. Jeziorski; P Rougier 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB